Interview with Professor Andy Davies, Southampton ECMC
News
Interview with Professor Andy Davies, Professor of Haematological Oncology at Southampton & Clinical Lead for TYA in Wessex
Interview with Dr Lynley Marshall, Royal Marsden paediatric ECMC
News
Interview with Dr Lynley Marshall, Oak Foundation Consultant in Paediatric and Adolescent Oncology Drug Development at The Royal Marsden Hospital
Interview with Professor Deborah Tweddle, Newcastle paediatric ECMC
News
Interview with Professor Deborah Tweddle Professor of Paediatric Oncology at Newcastle
International Summer School Opportunity
Event
Applications are now open to attend the CRUK Children’s Brain Tumour Centre of Excellence International Summer School. The Summer School, taking place on 11–14 July, is aimed at graduates, postdocs and early group leaders working in paediatric brain tumour research. Through a series of lectures, expert panels and team activities,...
Tackling slow set up times for Paediatric Clinical Trials
Basic page
The ECMC Network supports the delivery of early phase oncology trials in the UK, including complex innovative design and paediatric studies. Analysis of our portfolio shows that it takes on average 41 days longer to set up a paediatric trial compared to adult trials, and anecdotal reports from academic and...
TYA Patient Access
Basic page
A roadmap to help improve access to clinical research for teenagers and young adults (TYAs) with cancer The ECMC Network have launched a roadmap to improve access to clinical research for TYAs aged 16-24 with cancer. TYAs are less likely to participate in cancer research and we want to change...
ECMC Research Nurse training: Successful nursing in a phase I environment
News
Over the past year the ECMC Research Nurse Network Group has delivered training for more than 40 research nurses new to working in early phase cancer research. The aim of this training is to equip new early phase research nurses to deliver high quality, patient-centred care within the regulatory framework. The ECMC has run this training at various locations across the UK five times. We recognised the importance of ensuring that new research nurses continued to have the opportunity to access this training. The one-day in person training was updated to become two half-day online sessions.
ECMC Network Strategy: February 2022 Update
News
The ECMC Network Strategy was approved by the ECMC funders at the end of 2022. The Strategy has been developed in partnership with members of the ECMC network and stakeholders including industry, regulators and ECMC funders.
Working with UK Regulators
Basic page
The ECMC Programme Office has worked with key stakeholders to address some of the challenges associated with set up and conducting research in a system as complex as the NHS. Delivery of Complex Innovative Design Cancer Trials The traditional cancer drug development pathway has increasingly been superseded by trials that...
New regulatory routes for cancer treatment in Britain
Basic page
What do you need to know about post 2020 regulations? Speed, robust quality, safety and efficacy standards are an important feature in drug development and patient access. The departure of the UK from the EU in 2020 resulted in the Medicines and Healthcare products Regulatory Agency (MHRA) becoming a standalone...